Innovation Culture in Screening Drives Prenatal Genetic Testing Growth and Makes it Accessible to More Patients
New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow.
The study will help prenatal genetic testing providers understand the key trends emerging in the market (for the various prenatal tests offered in different geographic regions). It provides information on the state of the market and estimates its growth for the next 5 years, and it lists the unmet needs that companies must work on for their continuous growth. In addition, the study provides an overview of the major vendors offering tests, their market concentration, and different growth strategies.
The research service guides prenatal genetic testing providers in mapping strategic priorities and developing new capabilities to capitalize on emerging growth opportunities in this market based on current and expected numbers.
